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Materials and methods. For our research, as materials, were used: the SMN that contains 5137 
drugs, available on Medicines and Medical Devices Agency (amed.md) and also the scientific 
literature and guides on the classification of hepatoprotective products. 
Results. Hepatoprotective products have a lot of 2.1% of the total number of medicine from the 
nomenclature (5137), the first in the list are the drugs with vegetal origins: Silymarin products -
31, followed by ursodeoxycholic acid products -18, amino acid products -17, phospholipids 
products -9, and other different groups own an amount of 32 products. At the moment, the 
following products are absent from the pharmaceutical market: amino acid derivatives: Betaina 
citrat, Ornitin aspartat; drugs which contain phospholipids: Fosfolip, Lipin, Eplir; drugs with a 
animal origins: Sirepar, Vitogepat; and also synthetic drugs. According to the pharmaceutical 
forms, the hepatoprotective can be presented in capsules-55%, followed by tablets-26%, 
injectable solution-11%, oral solutions-7% and just 1% for vegetal products. We mention that 
reported to the manufacturing, 43% of hepatoprotective products are produced by EU, and 16% 
are produced in R. Moldova, etc. 
Conclusion. The National Program to combat the viral hepatitis for the years 2017-2021 
provides a reduction of 50% till 2021 of the incindence and prevalence for the acute and chronic 
hepatitis, including through the access of pacients with hepatitis to medical products and to 
quality treatment services.  
Key-words: hepatoprotective, products, hepatitis 
 
238. APPROACHES IN THE DRUG-INDUCED LUPUS ERYTHEMATOSUS  
 
Author: Nicolae Demenciuc  
Scientific adviser: Tatiana Rakovskaia, MD, PhD, Associate professor, Department of 
pharmacology and clinical pharmacology 
Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova 
 
Introduction. Drug-induced lupus erythematosus (DILE) is an autoimmune syndrome similar to 
systemic lupus erythematosus (SLE), caused by the long-term administration of certain drugs. 
The management of the disease is an important issue, because the pathogenesis and clinic 
manifestations of the disease have remained unclear. 
Aim of the study. Analysis of literature and new results regarding disease pathogenesis, clinical 
and laboratory manifestations, treatment and comorbidities in drug-induced lupus erythematosus. 
Material and methods. Selection and analysis of new literature in clinical practice, diagnostic and 
therapeutic approaches of drug-induced lupus erythematosus. 
Results. Over 80 drugs have high potential to induce DILE. The most common are; 
procainamide, hydralazine and quinidine. Drugs’ metabolism by the means of myeloperoxidase, 
their deacetylation of acetyl groups and the apoptosis with antinucleosomal antigen release are 
the basic links in the DILE pathogenesis. Diagnosis is made by determination of antinuclear 
and/or antihistronic antibodies. Most commonly used drugs for DILE control are: mycophenolate 
mofetil, cyclophosphamide, methylprednisolone, rituximab, belimumab, and blisibimod, 
indicated according to treatment schemes. 
Conclusions. The use of drugs must be individualized on the base of their efficacy and 
harmlessness. Recommended drugs in DILE treatment are prescribed according to their efficacy, 
accessibility, and evidence-based medicine and represent: glucocorticoids, immunosuppressants 
and B-cell blockade. 
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Introduction. Bioimpedance analysis is a noninvasive, low cost and a commonly used approach 
for body composition measurements and assessment of clinical setting. There is a variety of 
methods applied for interpretation of measured bioimpedance data and a wide range of 
utilizations of bioimpedance in body composition estimation and evaluation of clinical status. 
This method is currently becoming more widely used for diagnostics of various pathological 
disorders. 
Aim of the study. Revealing the conceptual basis and application of bioimpedance, as well as 
the method feasibility regarding physiological activity, body composition and chronic diseases 
assay. 
Materials and methods. Assaying the contemporary models concerning the implementation of 
bioimpedance in clinical research, including indirect assessment of physiological functions and 
body composition (fluid volumes and fat-free mass), classification of hydration, regional fluid 
accumulation, prognosis of disease and wound healing as well. 
Results. Increasing request for accurate, cost effective and non-invasive systems for clinical 
status monitoring and diagnosis of diseases, has accelerated the research endeavors to provide 
new methods and technologies for evaluation of the human body health. Body composition 
assessment tools have been considered a promising approach for the quantitative measurement of 
tissues characteristics over time, additionally to a direct assay of body composition equivalences 
and survival rate, clinical condition, illness and quality of life. 
Conclusions. Bioimpedance analysis is a growing method for body compartments estimation in 
nutrition studies, sportive medicine and evaluation of hydration rate, fat mass and fat free mass 
between healthy and diseased populations. Fat mass, fat free mass including skeletal muscle 
mass, bone minerals, and total body water are compartments that can be predicted and analyzed 
using suitable bioimpedance measurements techniques, procedures and special equations applied 
in population in concern to age, ethnic groups etc. 
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Introduction. Chronic kidney disease (CKD) is a worldwide public problem. There is a rising 
incidence and prevalence of kidney failure with poor outcomes and high cost. The guidelines 
define CKD as kidney damage or decreased glomerular filtration rate (GFR) less than 60 
mL/min/1.73m2 for at least 3 months. In Moldova, there were registered 490 patients with 
chronic kidney disease in 2017. Nowadays, dialysis and transplantation are 2 main solutions 
especially in end-stage kidney disease. Dialysis will prolong the life, but they will not have a 
normal life quality. Life expectancy of someone on dialysis is lower than that of the general 
population. Dialysis and transplantation are not fully available for all patients. 
Aim of the study. Analysis and comparing the data of latest studies performed in Europe and 
USA regarding new approach of CKD treatment, including exploring the field of artificial 
kidney grown in laboratories. 
